EDEN

NeuroOne® to Participate in the 36th Annual Roth Conference

Retrieved on: 
Friday, March 8, 2024

EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the 36th Annual Roth Conference being held March 17-19, 2024 in Dana Point, California.

Key Points: 
  • EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the 36th Annual Roth Conference being held March 17-19, 2024 in Dana Point, California.
  • Chief Executive Offer Dave Rosa and Chief Financial Officer Ron McClurg will host one-on-one meetings with institutional investors and analysts on Monday, March 18th and Tuesday, March 19th.
  • The Ritz Carlton, Laguna Niguel in Dana Point, California.

Winnebago Industries’ Second Quarter Fiscal 2024 Financial Results Announcement to be made on March 21, 2024

Retrieved on: 
Monday, March 4, 2024

EDEN PRAIRIE, Minn., March 04, 2024 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, plans to issue its earnings release for its second quarter fiscal 2024 before the market opens on Thursday, March 21, 2024.

Key Points: 
  • EDEN PRAIRIE, Minn., March 04, 2024 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, plans to issue its earnings release for its second quarter fiscal 2024 before the market opens on Thursday, March 21, 2024.
  • The Company will also host a conference call to discuss the financial results for the quarter on March 21, at 9 a.m. CT.
    All interested parties are invited to listen live via the Company's website, http://investor.wgo.net .
  • The event will be archived and available for replay for up to one year.
  • To access the replay, click on https://winnebago.gcs-web.com/event-calendar .

Winnebago Industries to Present at the 45th Annual Raymond James Institutional Investors Conference

Retrieved on: 
Tuesday, February 27, 2024

EDEN PRAIRIE, Minn., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, today announced that Senior Vice President and Chief Financial Officer, Bryan Hughes and Vice President, Investor Relations and Market Intelligence, Ray Posadas will present at the 45th Annual Raymond James Institutional Investors Conference in Orlando, Florida on Monday, March 4, 2024 at 8:05 a.m.

Key Points: 
  • EDEN PRAIRIE, Minn., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, today announced that Senior Vice President and Chief Financial Officer, Bryan Hughes and Vice President, Investor Relations and Market Intelligence, Ray Posadas will present at the 45th Annual Raymond James Institutional Investors Conference in Orlando, Florida on Monday, March 4, 2024 at 8:05 a.m.
  • ET.
  • A live webcast of the presentation will be available on Winnebago Industries’ investor relations website at http://investor.wgo.net .
  • The event will be archived and available for replay for 90 days.

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, February 23, 2024

EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective February 23, 2024, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan (the “Inducement Plan”), as a material inducement to one individual entering into employment with the Company.

Key Points: 
  • EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective February 23, 2024, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan (the “Inducement Plan”), as a material inducement to one individual entering into employment with the Company.
  • The equity award was approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of awards that are not made under a stockholder approved equity plan.
  • In connection with entering into employment with NeuroOne, the individual, who was not previously an employee or director of NeuroOne, received an option to purchase 65,000 shares of the Company’s common stock.
  • The option award has an exercise price of $1.07 per share, the closing price of NeuroOne’s common stock on February 23, 2024, the date of the grant.

SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders

Retrieved on: 
Thursday, February 22, 2024

EDEN PRAIRIE, MN, Feb. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the result of its special meeting (the “Special Meeting”) to approve its business combination with SEP Acquisition Corp.  The results, as reported in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on February 21, 2024 (Link), were as follows:

Key Points: 
  • At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp. by a vote of 798,379,869 “for” and 5,221,765 “against” with 71,525 abstaining
    EDEN PRAIRIE, MN, Feb. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the result of its special meeting (the “Special Meeting”) to approve its business combination with SEP Acquisition Corp.
  • Both proposals were approved, each receiving the affirmative requisite vote of the holders of shares of the Company’s common stock.
  • Although Proposal 2 was approved, the adjournment of the Special Meeting to solicit additional proxies was not necessary because there were sufficient votes at the time of the Special Meeting to adopt Proposal 1.
  • Each proposal is described in detail in the Company’s definitive proxy statement filed with the SEC on January 22, 2024.

Arctic Wolf Threat Report Highlights Sharp Rise in Ransom Demands and BEC Incidents

Retrieved on: 
Tuesday, February 20, 2024

EDEN PRAIRIE, Minn., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Arctic Wolf ®, a global leader in security operations, today published its annual Arctic Wolf Labs Threat Report .

Key Points: 
  • EDEN PRAIRIE, Minn., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Arctic Wolf ®, a global leader in security operations, today published its annual Arctic Wolf Labs Threat Report .
  • Created with threat, malware, digital forensics, and incident response case data that Arctic Wolf collects across the entire security operations framework, the Arctic Wolf Labs Threat Report delves deep into the cybercrime ecosystem, highlighting current global threat trends and offering strategic cybersecurity recommendations for the year ahead.
  • “Resources like the Arctic Wolf Labs Threat Report assist carriers and businesses in understanding the current and future cybersecurity landscape.
  • For additional insights from the 2024 Arctic Wolf Labs Threat Report, visit arcticwolf.com to download the full report .

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, February 13, 2024

Total operating expenses in the first quarter of fiscal 2024 were $3.7 million, compared with $3.2 million in the first quarter of fiscal 2023.

Key Points: 
  • Total operating expenses in the first quarter of fiscal 2024 were $3.7 million, compared with $3.2 million in the first quarter of fiscal 2023.
  • R&D expense in the first quarter of fiscal 2024 was $1.5 million compared with $1.6 million in the same period of fiscal 2023.
  • SG&A expense in the first quarter of fiscal 2024 was $2.2 million compared with $1.7 million in the first quarter of fiscal 2023.
  • Net loss was $3.3 million for the first quarter of fiscal 2024, compared to a net loss of $1.7 million in the first quarter of fiscal 2023.

Arctic Wolf Recognized by Customers With Highest Overall Rating and Willingness to Recommend Score in 2024 Gartner Peer Insights™ Voice of the Customer for Vulnerability Assessment

Retrieved on: 
Tuesday, February 13, 2024

EDEN PRAIRIE, Minn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Arctic Wolf ®, a global leader in Security Operations, today announced that it has been named a Strong Performer in the January 2024 Gartner Peer Insights Voice of the Customer for Vulnerability Assessment.

Key Points: 
  • EDEN PRAIRIE, Minn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Arctic Wolf ®, a global leader in Security Operations, today announced that it has been named a Strong Performer in the January 2024 Gartner Peer Insights Voice of the Customer for Vulnerability Assessment.
  • Of the nine vendors mentioned in the report, Arctic Wolf Managed Risk had the highest overall rating (4.7 out of 5) and the highest willingness to recommend (96%) based on 74 reviews as of January 15, 2024.
  • With Arctic Wolf Managed Risk, organizations of virtually any size get a turnkey solution that empowers them to rapidly identify, prioritize, and mitigate the most critical vulnerabilities impacting their business,” said Dan Schiappa, chief product officer, Arctic Wolf.
  • In the December 2023 Gartner Peer Insights Voice of the Customer for Security Awareness Computer-based Training, Arctic Wolf Managed Security Awareness was recommended by 98% of reviewers based on 22 reviews submitted as of November 2023.

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

Retrieved on: 
Thursday, February 8, 2024

EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on February 13, 2024 at 4:30 PM Eastern Time to discuss financial results for its first quarter of fiscal year 2024 ended December 31, 2023, and provide a corporate update.

Key Points: 
  • EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on February 13, 2024 at 4:30 PM Eastern Time to discuss financial results for its first quarter of fiscal year 2024 ended December 31, 2023, and provide a corporate update.
  • Conference Call and Webcast Information:

DDL Enhances its Medical Connector Testing Capabilities with the Addition of Industrial CT Scanning Technology for Dimensional Analysis

Retrieved on: 
Tuesday, February 6, 2024

EDEN PRAIRIE, Minn., Feb. 6, 2024 /PRNewswire-PRWeb/ -- DDL, a third-party testing laboratory, announced it has enhanced its medical connector testing capabilities with the addition of Industrial CT scanning to provide dimensional testing to meet the exacting dimensional criteria outlined in the ISO 80369 standard.

Key Points: 
  • EDEN PRAIRIE, Minn., Feb. 6, 2024 /PRNewswire-PRWeb/ -- DDL, a third-party testing laboratory, announced it has enhanced its medical connector testing capabilities with the addition of Industrial CT scanning to provide dimensional testing to meet the exacting dimensional criteria outlined in the ISO 80369 standard.
  • ISO 80369 is a set of standards created for small-bore connectors utilized in healthcare applications, encompassing the Luer Lock design.
  • Adhering to these standards empowers medical device manufacturers to elevate patient safety, diminish the likelihood of misconnections, and guarantee compatibility between devices from diverse manufacturers.
  • For more information on DDL's Industrial CT scanning capabilities and other testing services, or to receive a quote, please visit http://www.DDLtesting.com or call us at 800-229-4235.